Barely Significant
← all excerpts

B cell targeted therapies.

Arthritis Res Ther · 2005 · PMC2833972 · PMID 15960817

Europe PMCDOI
1
hedged sentence
0.0590
closest p · 1.2× alpha
0.0590
boldest claim

The sentences

failed to reach statistical significanceP = 0.059so close (0.05 < p ≤ 0.1)
Investigators also noted that the number of patients achieving an ACR50 response in the group receiving rituximab alone was greater than that in the control group, but this failed to reach statistical significance ( P = 0.059).

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.